APUS 株価分析 — Apimeds Pharmaceuticals US, Inc. (Healthcare >> Drug Manufacturers - Specialty & Generic)
APUS に関するよくある質問
APUSのROE(自己資本利益率)は?
Apimeds Pharmaceuticals US, Inc.のROEは-32.14%です。
APUSの配当利回りは?
Apimeds Pharmaceuticals US, Inc.の配当利回りは0.00%です。
APUSの品質スコア(Quality Score)は?
当社のAIはAPUSの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
APUSは今が買い時ですか?
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
APUSはどのセクターに属しますか?
Apimeds Pharmaceuticals US, Inc.はHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます(NYSE MKT市場)
APUS AI Analysis Summary
Our AI summary for APUS: Apimeds Pharmaceuticals US, Inc. (NYSE MKT), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 0.00, ROE of -32.14%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 4.65
Price
-0.27
(-5.49%)
Day Change
|
|
|---|
APUS, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 4.65 |
| PBV / Sector |
0.06 / 10.19
GREAT
|
| Earning Per Share | -25.46 |
| PE / Sector |
N/A / 31.74
|
| PEG or PE/Growth / Sector |
N/A / -0.02
|
| Average 1M Daily Value |
0.22 M
GREAT
|
| Average 1W Daily Value |
0.23 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
47% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-06 07:59:38 |
| Symbol | APUS |
| Name | APIMEDS PHARMACEUTICALS US, INC. |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE MKT |
| Listed Shares | 1.51 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 7.42 / 10,556.24 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 100 Matawan Rd, Matawan, NJ, United States, 07747
Phone: 848 201 5010
Website: https://www.mindwavedao.com
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Google